The mature vertebrate heart develops from a simple linear cardiac tube during early 17 development through a series of highly asymmetric morphogenetic processes including cardiac 18 looping and chamber ballooning. While the directionality of heart morphogenesis is partly 19 controlled by embryonic laterality signals, previous studies have suggested that these extrinsic 20 laterality cues interact with tissue-intrinsic signals in the heart to ensure robust asymmetric 21 cardiac morphogenesis. Using live in vivo imaging of zebrafish embryos we describe a left-22 sided, chamber-specific expansion of the extracellular matrix (ECM) between the myocardium 23 and endocardium at early stages of heart morphogenesis. We use Tomo-seq, a spatial 24 transcriptomic approach, to identify transient and regionalised expression of hyaluronan and 25 2 proteoglycan link protein 1a (hapln1a), encoding an ECM cross-linking protein, in the heart 26 tube prior to cardiac looping overlapping with regionalised ECM expansion. Loss-and gain-27 of-function experiments demonstrate that regionalised Hapln1a promotes heart morphogenesis 28 through regional modulation of ECM thickness in the heart tube. Finally, we show that while 29 induction of asymmetric hapln1a expression is independent of embryonic left-right 30 asymmetry, these laterality cues are required to orient the hapln1a-expressing cells 31 asymmetrically along the left-right axis of the heart tube. 32
Introduction 37
Congenital heart defects are the most common human birth abnormality, with an incidence of 38 approximately 1% of live births (van der Linde et al. 2011 ; Hoffman & Kaplan 2002) . These 39 structural malformations arise due to abnormal morphogenesis and maturation of the heart 40 during embryonic development. A key stage in cardiac development is when the heart 41 transitions from a linear tube to an asymmetric organ, a process including initial looping 42 morphogenesis of the tube and subsequent ballooning of the cardiac chambers. Correct cardiac 43 morphogenesis is vital for ensuring normal blood flow through the heart, proper chamber and 44 vessel alignment, valve formation and septation. Therefore early cardiac morphogenesis is a 45 tightly controlled process, and requires coordination of heart-extrinsic signalling cues, cardiac 46 growth and tissue-intrinsic changes in cell shape, mediated by cytoskeletal rearrangements 47 (Desgrange et al. 2018) . 48
The requirement for embryonic left-right signalling pathways in promoting directionality of 49 heart morphogenesis is well established, with asymmetric Nodal signalling playing a key role 50 5 regional ECM thickness in the heart tube we used live in vivo light-sheet microscopy to image 101 quadruple transgenic zebrafish embryos at 26 hours post fertilisation (hpf). 102 Tg(myl7:lifeActGFP); Tg(fli1a:AC-TagRFP); Tg(lft2BAC:Gal4FF); Tg(UAS:RFP) zebrafish 103 express actin-tagged GFP in the myocardium (Reischauer et al. 2014 ) and actin-localised RFP 104 in the endothelium including the endocardium (Savage et al. 2019) , allowing visualisation of 105 the two tissue layers in the heart tube. The Tg(lft2BAC:Gal4FF); Tg(UAS:RFP) double 106 transgenic drives RFP in lefty2-expressing cells, which comprises the dorsal myocardium of 107 the heart tube at 26hpf ( Fig 1A and Fig S1) (Smith et al. 2008; Baker et al. 2008 ). This 108 combination of transgenes allowed imaging of optical cross sections through the heart tube at 109 26hpf, just prior to onset of looping morphogenesis, and enabled dorsal-ventral axis orientation 110 of the heart tube ( Fig 1A-G , Supplemental Movie 1). We consistently observed an asymmetry 111 in the extracellular space between the myocardial and endocardial layers of the heart in the 112 atrium, with an apparent thickening of the ECM on the left side of the tube which is maintained 113 throughout the cardiac cycle ( Fig 1D, G) . With this combination of transgenes, we could 114 quantify the extracellular space between the two tissue layers of the heart tube and calculate 115 the ECM asymmetry ratio (left ECM thickness divided by right ECM thickness, where a value 116 of >1 indicates a left sided expansion). Using this method, we detected a reproducible 117 expansion of the ECM in the left side of the heart tube ( Fig 1H) . Further characterisation also 118 found that the left-sided ECM expansion is maintained in the atrium at 50hpf ( Fig S2) . 119
Due to limited ability to image deeper cardiac tissue with sufficient resolution at 26hpf, we 120 could only image the relatively superficially located venous pole/atrium of the heart tube in 121 live embryos. Therefore, to determine whether ECM left-right asymmetry is restricted to the 122 atrium of the heart tube or is maintained along the atrioventricular axis of the heart, we 123 performed fixed tissue imaging. Previous studies have demonstrated that hyaluronic acid (HA) 124 is present in the cardiac jelly during zebrafish heart development (Grassini et al. 2018; 125 data demonstrate that the heart tube exhibits an asymmetrically expanded ECM prior to onset 138 of looping morphogenesis. 139 140 hapln1a exhibits regionalised cardiac expression prior to heart morphogenesis. 141
The asymmetric expansion of the cardiac ECM could be due to regionalised synthesis of ECM 142 components. However, we did not observe any clear asymmetry in levels of HA deposition in 143 the cardiac ECM in either live embryos injected with the ssNcan-GFP sensor ( Fig S3) or in 144 fixed hearts ( Fig 1I-K) . We also did not find any anteroposterior asymmetry in the heart disc, 145 or left-right asymmetry in the heart tube in the expression of hyaluronan synthase 2 (has2, the 146 major HA producing enzyme), chondroitin sulfate synthase 1 (chsy1) or the ECM 147 Fig S3) , suggesting that 7 regionalised synthesis of these proteins does not cause ECM asymmetry. We therefore 151 hypothesised that a protein required either for HA modification or cross-linking may be 152 regionally expressed in the heart tube prior to looping morphogenesis and promote regionalised 153
ECM expansion. 154
To identify candidate genes which modulate cardiac ECM expansion, we took a genome-wide 155 approach to identify genes expressed in the heart tube at 26hpf, prior to the onset of looping 156 morphogenesis. Since we observed the strongest left-sided ECM expansion in the putative 157 atrium, as well as a generally more expanded ECM at the venous pole of the heart compared 158 to the arterial pole, we used the previously described Tomo-seq technique to generate a 159 regionalised map of gene expression from pole-to-pole in the heart tube (Junker et al. 2014; 160 Burkhard & Bakkers 2018) ( Figure 2A ). We sectioned two individual hearts along the 161 atrioventricular axis, identifying 6,787 and 8,916 expressed genes (see Supplementary Tables  162   2-5) , of which approximately half were expressed in more than one section. By identifying 163 which sections express the atrial marker myh6 (myosin, heavy chain 6, cardiac muscle, alpha) 164
we defined a subset of tissue sections with atrial identity. We subsequently filtered genes that 165 are up-regulated in atrial sections compared to ventricular sections in both hearts and examined 166 this list for genes which may be implicated in ECM modification. 167
Using this approach we identified hyaluronan and proteoglycan link protein 1a (hapln1a, 168 formerly crtl1) as a candidate that might drive regionalised ECM expansion ( Fig 2B) . The 169
Hapln family of proteins are secreted into the ECM where they crosslink HA to proteoglycans 170 (Spicer et al. 2003 ), suggesting Hapln1a may act to modify the cardiac ECM environment. 171 Furthermore, Hapln1 mutant mice exhibit heart malformations including septal defects and 172 perturbations of the inflow and outflow tracts, consistent with abnormal heart morphogenesis 173 (Wirrig et al. 2007) . 174 8 mRNA in situ hybridisation analysis revealed that hapln1a is expressed in the posterior of the 175 heart disc and the cardiac cone ( Fig 2C, D) . At 26hpf hapln1a expression is upregulated on the 176 left side of the cardiac tube with elevated levels of expression of hapln1a in the future atrium 177 compared to the future ventricle, recapitulating the regionalised ECM expansion we observe 178 in the heart (compare Fig 2E and Fig 1K) . This is in line with recent studies demonstrating that 179 the posterior compartment of the cardiac disc is re-positioned to the left side of the heart tube 180 (Guerra et al. 2018) . By 50hpf hapln1a expression is restricted to very low levels in the 181 atrioventricular canal, the precursor to the atrioventricular valve ( Fig 2F) . Fluorescent in situ 182 hybridization reveals hapln1a is expressed in the myocardium ( Fig 2G-I 
), while analysis of 183
Hapln1a protein localisation confirms it is deposited in the ECM (Fig 2J-L) . Despite the 184 absence of hapln1a expression in the heart at 50hpf ( Fig 2F) , Hapln1a protein is maintained in 185 the ECM at 50hpf ( Fig 2M-Q) , suggesting that the ECM environment established during early 186 stages prior to heart tube formation is maintained during heart development and may be 187 important for continued cardiac morphogenesis. 188 189
Hapln1a is required for heart morphogenesis and promotes ECM expansion. 190
To determine whether Hapln1a is required for cardiac morphogenesis we used CRISPR-Cas9-191 mediated genome editing to generate hapln1a mutants. We injected a pair of guide RNAs 192 targeting approximately 200bp upstream of the translation-initiating ATG and immediately 193 downstream of the ATG, allowing us to excise the putative promoter of hapln1a ( Fig S4) . We 194 recovered F1 adult fish carrying two deletions; a 187bp deletion (hapln1a D187 ) and a 241bp 195 deletion (hapln1a D241 ), both of which remove the initiating ATG and upstream sequence, and 196 established both as stable lines at F2. To confirm the deletions removed the hapln1a promoter 197 and prevented transcription, hapln1a expression was analysed at 26hpf in F3 mutant embryos 198 for each allele. Homozygous hapln1a promoter mutants of either allele exhibit a complete loss 9 of hapln1a expression at 26hpf compared to wild type embryos ( Fig 3C, E, Fig S4) , 200 demonstrating successful deletion of the hapln1a promoter, and confirming the promoter 201 mutants as loss of function models. Furthermore, embryos heterozygous for a hapln1a 202 promoter mutation also exhibit a reduction in levels of transcript compared to wild type siblings 203 ( Fig 3D, Fig S4) . Analysis of heart development in hapln1a D241 mutants at 50hpf did not reveal 204 striking abnormalities in cardiac morphogenesis ( Fig 3F-H) , however we did observe 205 occasionally mispositioned and malformed atria. To investigate this further, we examined 206 morphology of individual chambers at 50hpf by in situ hybridization analysis of the ventricular 207 marker myh7l (myosin heavy chain 7-like) and the atrial marker myh6 (Fig 3I-N) . 208
Quantification of either whole heart size, or individual chamber size revealed a significant 209 reduction in whole heart size in hapln1a D241 mutants when compared to wild type siblings (Fig  210   3R ), and a mild reduction in atrium size ( Fig 3S) . We observed a similar significant reduction 211 in atrial size in the second hapln1a D187 allele ( Fig S4) . To quantify cardiac morphology at 50hpf 212 we defined the looping ratio, a quotient of the looped and linear distances ( Fig S4 and  213 Methods). Although homozygous hapln1a mutants exhibit a reduction in cardiac size, we 214 observed no significant reduction in looping ratio ( Fig 3U, Fig S4) . 215
To assess the impact of loss of hapln1a on continued morphogenesis of the heart we used live 216 light sheet imaging of Tg(myl7:lifeActGFP); Tg(fli1a:AC-TagRFP) transgenic embryos, 217 acquiring 3D images of the heart at 72hpf. We found that hapln1a D241 mutant hearts appear 218 dysmorphic at 72hpf, with abnormally positioned atria and disrupted heart looping compared 219 to wild type ( Fig 3O-Q ). Together this demonstrates that similar to mouse, hapln1a is required 220 for cardiac morphogenesis. 221
Since Hapln1 functions as an ECM binding protein and its localisation recapitulates the 222 regionalised ECM expansion in the heart tube prior to heart morphogenesis, we hypothesized 223 that Hapln1a promotes cardiac morphogenesis by driving regionalised ECM expansion in the 224 heart. Since both hapln1a promoter deletion alleles carry the Tg(myl7:lifeActGFP) transgene, 225 this prevented analysis of ECM width throughout the heart tube of hapln1a mutants using the 226 ssNcan-GFP HA sensor. Therefore, to examine ECM asymmetry in the heart tube upon loss 227 of hapln1a, we injected a morpholino (MO) against hapln1a into zebrafish embryos at the 1-228 cell stage together with a tp53 MO control and the ssNcan-GFP HA sensor and assessed ECM 229 expansion in the heart tube at 26hpf. Analysis of Hapln1a protein levels in hapln1a morphants 230 confirms successful blocking of Hapln1a translation in the morphants ( Fig S5) . Control 231 embryos injected with tp53 MO demonstrate the regionalised ECM expansion previously 232 observed, with a left-sided expansion of the ECM ( Fig 4A-B) , and a higher level of ECM 233 expansion in the atrium versus the ventricle ( Fig 4C) . Embryos injected with hapln1a MO + 234 tp53 MO did not exhibit either atrial or left-sided ECM expansion ( Fig 4A, 
Hapln1a and HA interact to drive heart morphogenesis 244
Hapln1a is a member of a family of ECM binding proteins which crosslink hyaluronan with 245 proteoglycans in the ECM (Spicer et al. 2003 ). Since hapln1a is transiently expressed at cardiac 246 disc and early tube stage, this suggests that the cardiac ECM that drives continued 247 morphogenesis of the heart is established at early stages of heart development and requires the 248 interaction of Hapln1a with hyaluronic acid. To interrogate the temporal requirements for HA 249 in heart looping, we applied the HA synthesis inhibitor 4-Methylumbelliferone (4-MU 250 (Nakamura et al. 1997; Ouyang et al. 2017) ) to embryos prior to the onset of heart tube 251 formation at 18hpf, and either washed the drug off at 22hpf, or left the embryos to develop to 252 50hpf, when we assessed heart looping morphology. Inhibiting HA synthesis from cardiac disc 253 stage (18hpf) until 50hpf often arrested heart development mid-way during tube formation (Fig  254   S6 ), a more profound phenotype than that observed in has2 zebrafish morphants or Has2 mouse 255 mutants (Smith et al. 2008; Camenisch et al. 2000) . However, inhibition of HA synthesis during 256 the short time window between cardiac disc (18hpf) and cardiac cone (22hpf) stage, prior to 257 tube formation, resulted in normal tube formation but a specific disruption to heart looping 258 morphogenesis ( Fig S6) . This supports the hypothesis that HA synthesised prior to formation 259 of the heart tube is required for looping morphogenesis of the heart. 260
Having demonstrated a requirement for HA synthesis for heart morphogenesis during early 261 cardiac development when hapln1a expression is initiated, we wanted to confirm the 262 interaction of hapln1a and HA in heart looping morphogenesis. Injection of sub-phenotypic 263 doses of morpholinos targeting either has2 or hapln1a did not result in significant defects in 264 cardiac morphology at 48hpf ( Fig S6) . However, co-injection of both has2 and hapln1a 265 morpholinos results in profound defects in heart morphology at 48hpf ( Fig S6) , including a 266 reduction in heart looping ratio, and abnormal atrial morphology. This more profound 267 phenotype than that observed by either injection of hapln1a MO + tp53 MO, has2 MO + tp53 268 MO, 4MU treatment or deletion of the hapln1a promoter, suggesting that while timely HA 269 signaling drives heart morphogenesis subsequent to tube formation, hapln1a is an important 270 regional modulator of this process. 271
272
While analysis of hapln1a mutants demonstrates a requirement for Hapln1a in heart 273 development (Fig 3) , we wished to investigate whether the regionalization of hapln1a 12 expression is important for cardiac morphogenesis. We generated a DNA construct in which 275 the full length hapln1a coding sequence is driven by the pan-myocardial myl7 (myosin light 276 chain 7) promoter, flanked by Tol2 transposon sites to allow integration into the genome (Fig  277   5A ). We co-injected myl7:hapln1a DNA with tol2 transposase mRNA at the 1-cell stage and 278 analysed both myl7 and hapln1a expression at 50hpf, allowing us to visualize heart morphology 279 alongside assessing the extent of hapln1a misexpression (Fig 5B,C) . We quantified the looping 280 ratio ( Fig S4) , as well as the percentage coverage of hapln1a expression in the whole heart and 281 plotted percentage coverage against looping ratio ( Fig 5D) . We found that increasing the 282 domain of hapln1a expression in the heart results in a reduction in looping morphogenesis ( Fig  283   5D ), suggesting that regionalised expression of hapln1a in the heart is important for proper 284 cardiac morphogenesis. Since hapln1a is expressed at higher levels in the atrium than the 285 ventricle and ECM asymmetry is more robust in the atrium, we hypothesized that hapln1a 286 misexpression in each chamber may impact differently on heart morphogenesis. We quantified 287 hapln1a misexpression in each chamber by calculating the percentage of the chamber which 288 expresses hapln1a ( Fig 5E-I) , and found that while misexpression of hapln1a in the ventricle 289 did not impact upon heart morphogenesis ( Fig 5J) , misexpression of hapln1a in the atrium 290 resulted in abnormal cardiac morphogenesis ( Fig 5K) . This suggests that spatially-restricted 291 hapln1a expression in the atrium drives cardiac morphogenesis. 292
293
Finally, since Hapln1a is asymmetrically expressed on the left side of the heart tube, and is 294 required for heart morphogenesis, we hypothesized that it may contribute to a previously-295 described tissue-intrinsic mechanism of heart looping morphogenesis (Noël et al. 2013 in left-right asymmetry, including a disruption to normal leftward displacement of the heart 301 tube (Schottenfeld et al. 2007 ). We hypothesised that induction of hapln1a expression occurs 302 independent of embryonic laterality cues, but that asymmetric positioning of hapln1a-303 expressing cells in the heart tube may be tightly linked to the direction of heart tube position, 304 and therefore dictated by embryonic left-right asymmetry. We analysed hapln1a expression 305 in an incross of pkd2 hu2173 heterozygotes and found that consistent with our hypothesis hapln1a 306 is always expressed in the posterior of the heart disc in pkd2 hu2173 mutants at 22hpf ( Fig 6D) , 307 demonstrating that initiation of hapln1a expression is laterality independent. Importantly, at 308 26hpf we observed that positioning of hapln1a-expressing cells is dependent upon cardiac 309 position -in embryos where the heart is positioned to the right, hapln1a is upregulated on the 310 right side of the tube, whereas if the heart remains midline, hapln1a does not exhibit a clear 311 left-right asymmetry in up-regulation ( Fig 6A-C, E) . These data support a model where 312 laterality cues do not initiate hapln1a expression but are required for its subsequent position in 313 the heart tube. To further investigate our model we analysed Hapln1a protein localisation in 314 spaw mutant embryos, which lack asymmetric Nodal expression prior to asymmetric organ 315 morphogenesis (Noël et al. 2013) . spaw mutant embryos exhibit midline hearts at 26hpf and 316
Hapln1a is no longer positioned on the left side of the heart tube as observed in sibling embryos, 317 but instead is secreted into the cardiac ECM on the ventral face of the heart ( Figure 6F-M) . 318
Together, we propose a model where initiation of hapln1a expression in the posterior cardiac 319 disc is independent of KV-based laterality cues, but the subsequent cell movements which 320 occur during heart tube formation reposition this population of cells to the left side of the heart, 321 dictating the axis of ECM asymmetry in the heart tube (Guerra et al. 2018 ). Therefore, 322 embryonic laterality positions the regionally specialized ECM in the heart tube, ensuring that 323 directionality and growth of the heart are tightly coordinated to fine tune cardiac 324 morphogenesis. ( Figure 6N ). 325 326 Discussion 327
Our data show that prior to heart looping morphogenesis in zebrafish, the heart tube exhibits 328 regionalised ECM expansion that is dependent upon localised expression of the ECM binding 329 protein hapln1a and this is required to promote proper cardiac morphogenesis. Our findings 330 build upon previous studies showing that Hapln1 mutant mouse embryos exhibit structural 331 cardiac malformations consistent with abnormal early cardiac morphogenesis (Wirrig et al. 332 2007) . While that study describes expression of Hapln1 in the valve leaflets at later stages of 333 heart development, it does not address a potentially conserved role for transiently asymmetric 334
Hapln1 expression at earlier stages of heart development. Zebrafish have two hapln1 paralogs, 335
and each gene has a very distinct expression profile in the heart during development, with 336 hapln1b being expressed primarily in the endocardium and atrioventricular canal (data not 337 shown). Thus zebrafish provide an opportunity to define tissue-specific requirements for 338
Hapln1 function in either the myocardium or endocardium during cardiac morphogenesis, 339 dissecting better the specific roles for Hapln1 in cardiac development. 340 hapln1a mutants exhibit mild defects in cardiac morphology at embryonic stages, with atrial 341 morphology predominantly affected. Interestingly, the only other gene shown to be expressed 342 in the posterior cardiac disc/left heart tube in zebrafish is meis2b (Guerra et al. 2018 ). Analysis 343 of meis2b mutants revealed defects in atrial morphology at juvenile and adult stages, supporting 344 our conclusion that early anterior-posterior asymmetry in the heart disc/left-right asymmetry 345 in the heart tube are important for continual cardiac morphogenesis. However, contrary to our 346 study which reveals a reduced atrial size in hapln1a mutants, meis2b mutant adult zebrafish 347 exhibit an enlarged atrium (Guerra et al. 2018) suggesting that while they are expressed in the same domain, these two genes regulate atrial morphogenesis differently. hapln1a mutants are 349 adult viable (data not shown), therefore it would be interesting to determine whether the atrium 350 remains underdeveloped in hapln1a mutants, or whether they also develop a hyperproliferative 351 atrial hypertrophy phenotype by adulthood. 352
A major role of the ECM in tissue morphogenesis is to provide structural or biomechanical 353 cues to neighbouring tissues. While hapln1a is expressed prior to tube formation and during 354 very early stages of looping morphogenesis only, Hapln1a protein persists in the cardiac jelly 355 even after the heart has undergone initial looping morphogenesis (Fig 2) . Together with our 356 data demonstrating that HA synthesis is required prior to heart tube formation to promote 357 cardiac morphogenesis ( Fig S6) , this suggests that the ECM environment generated early 358 during heart development is crucial for continual and/or maintenance of chamber 359 morphogenesis. Interestingly, recent studies have demonstrated that Hapln1 is the key element 360 required for tissue folding in the human neocortex, and that HA is required to maintain the 361 architecture of the tissue after folding has occurred (Long et al. 2018 ). In light of this, we 362
propose that formation of the specific ECM environment at cardiac disc stage is required to 363 ensure the heart maintains correct shape as it undergoes early looping morphogenesis. 364
Alternatively, Hapln1a-mediated cross-linking may modulate regional stiffness of the cardiac 365 ECM. Differential matrix stiffness has been shown to regulate a wide variety of cellular Hapln proteins act as structural modifiers of the ECM, cross-linking HA to proteoglycans. As 375 previously discussed, regional ECM crosslinking may change the biomechanical properties of 376 the ECM by stabilising these components in specific regions of the heart tube. However, both 377 HA and proteoglycan cleavage products can act as signalling molecules (Iozzo & Schaefer 378 2015) . Hapln1 mouse mutants exhibit a decrease in protein levels of the proteoglycan Versican 379 Recent studies have shown that cross talk between the myocardium and endocardium 397 modulates atrial growth (Bornhorst et al. 2019) , and differential ECM composition and/or 398 degradation may help regionally fine tune this process to dictate chamber morphology. 399
Therefore determining whether the regionalised cardiac ECM plays a structural role or is 400 required for modulation of extracellular signalling will be an important step in understanding 401 how these cell layers interact to drive correct chamber morphogenesis. 402
Analysis of hapln1a expression in pkd2 mutant embryos, which have defective KV function 403 and randomised left-right asymmetry (Schottenfeld et al. 2007 ) demonstrates that posterior up-404 regulation of hapln1a in the cardiac disc is not dependent upon KV function. However, we 405 observe that in pkd2 mutants where asymmetry of the heart is reversed and the heart tube 406 extends to the right, due to the cellular movements required for tube formation hapln1a-407 expressing cells are positioned on the right side of the heart tube instead of the left (Fig. 6) . We 408 propose a model in which while antero-posterior patterning of the heart disc is laterality-409 independent, since laterality signals promote cardiac disc rotation and heart tube displacement, 410 this results in hapln1a asymmetry along the left-right axis of the heart tube. This generates 411 lateral ECM asymmetry in the heart, promoting robust looping and chamber ballooning 412 morphogenesis ( Figure 6N ). This would begin to explain previous observations that heart tube 413 position prior to looping predicts the direction of looping morphogenesis (Baker et al. 2008; 414 Chen et al. 1997), since the direction of heart tube extension will dictate lateralised ECM 415 asymmetry in the tube. In addition, we show that in embryos lacking Nodal signalling, Hapln1a 416 is positioned on the ventral face of the heart (Fig 6) . Together with our previous observations 417 that the heart disc of spaw mutants undergo a very mild level of rotation and that the direction 418 of this limited rotation is consistent with the final outcome of looping direction (Noël et al. 419 2013), it is possible that even slight rotation in the heart disc is sufficient to set up mild 420 asymmetry in the ECM that can go on to promote directional looping, supporting the 421 hypothesis that these pathways may act together to robustly ensure directional looping 422
morphogenesis. 423
Together this study elaborates upon our previously proposed model where laterality-based 424 extrinsic cues feed into a tissue-intrinsic mechanism of heart looping to promote robust 425 directional cardiac morphogenesis. regression of the data (n=194). Spearman's correlation coefficient (r) deviates significantly 541 from zero demonstrating that increased coverage of hapln1a in the myocardium results in 542 reduced heart looping morphogenesis. E-I: Illustration of quantification approach to analyse 543 pan-cardiac or chamber-specific hapln1a overexpression at 55hpf. Embryos are stained for 544 myl7 and hapln1a mRNA (E), and images are split into red, blue and green channels. The green 545 23 channel (F) highlights the myl7 expression in the heart and is used to manually draw round the 546 ventricle and atrium. The red channel highlights the hapln1a expression (G), and is first 547 processed to subtract the background, before the chamber ROIs are applied (G). Each chamber 548 ROI is isolated, the surrounding image cleared, and a threshold is applied to the hapln1a 549 staining within the ROI (H-I). The number of pixels within the chamber ROI is then measured, 550 alongside the total area of the ROI, quantifying percentage of the chamber expressing hapln1a. Tg(lft2BAC:Gal4FF); Tg(UAS;RFP), pkd2 hu2173 , hapln1a promD241 (allele designation 579 hapln1a sh580 ), hapln1a promD187 (allele designation hapln1a sh578 ). Embryos older than 24hpf were 580 treated with 0.2 mM 1-phenyl-2-thiourea (PTU) in E3 medium to inhibit melanin production. 581 582
Generation of hapln1a mutants 583
To generate hapln1a mutant zebrafish lines, CRISPR guide RNAs (gRNA) were designed to 584 target the putative promoter region of hapln1a (GRCz11: ENSDART00000122966.4, g1: 5'-585 TCGTCTCTCTCTAAGGGGAGGGG-3') and the downstream region of the translation start 586 site (g2: 5'-GATGATTGCTCTGTTTTCTGTGG-3'). Sequence-specific CRISPR RNAs 587 (crRNA) were synthesised by Merck, resuspended in MilliQ water to 21.4µM, and injected 588 together with an equimolar concentration of trans-activating RNA (tracrRNA, Merck) and 589
Cas9 protein (NEB M0386T) into the yolk of 1-cell stage embryos in a volume of 1nl. CRISPR-590
Cas9-injected embryos were raised to adulthood (F0) and individuals transmitting putative 591 promoter deletions in the germline were identified by outcrossing to wildtype. Embryos 592 collected from these outcrosses were genotyped by PCR using the following primers to amplify 593 the putative promoter region of hapln1a: forward 5'-ACATTTTGCATGCCCTCGAA-3'; 594 reverse 5'-TGCATCCTGGACCTTCATTCA-3'. Successful promoter deletion was identified 595 RNA extraction, aRNA synthesis, library preparation, sequencing and data analysis was 671 performed as previously described (Burkhard & Bakkers 2018; Junker et al. 2014) . 672 673
Morpholino-mediated knockdown and hapln1a overexpression analysis 674
The following morpholino was designed to target the translational start site of hapln1a 675 Live zebrafish embryos were imaged on a ZEISS Lightsheet Z.1 microscope at 72hpf. To 711 assess cardiac morphology at 72hpf embryos were anesthetised with tricaine before mounting 712 in 1% low melting point agarose in E3 with 8.4% tricaine, using black capillaries. To stop the 713 heart the imaging chamber was filled with E3 plus tricaine (8.4%) and the temperature 714 maintained at 10°C. All samples were imaged using a 20X lens and 1.0 zoom. Dual side lasers 715 with dual side fusion and pivot scan were used for sample illumination. Image stacks were 716 initially processed using Vision4D (Arivis AG, Germany) and Fiji. Processing steps included 717 noise removal, background correction, and subsequent application of individual morphological 718 filters to each channel to sharpen the edges of the myocardial and endocardial tissue layers. 719
Maximum intensity z-projections of the composite channels were used to visualise cardiac 720 morphology the centreline of the heart was manually traced. Optical transverse sections 721 perpendicular to the centreline were generated at regularly-spaced intervals originating from 722 the venous pole into the atrium to visualise the cardiac ECM. 723
Embryos injected with ssNcan-GFP mRNA were fixed overnight in 4% PFA, and 724 immunohistochemistry was carried out to amplify the GFP signal. Embryos were dissected 725 and imaged using a Zeiss Airyscan microscope, and z stacks were obtained with a z-step size 726 of 1µM. Images were Airyscan processed using Zen Black software (Zeiss), and the resulting 727 image stacks were optically resliced using Fiji. ECM width was manually measured in Fiji. 728 ECM measurements were aligned between samples at the venous pole of the heart for plotting. 729
Looping ratio was calculated from images of myl7 expression detected by ISH. All samples 730 from one experimental set were blinded using the ImageJ Blind_Analysis plugin 731 (https://github.com/quantixed/imagej-macros/blob/master/Blind_Analysis.ijm). The linear 732 distance from arterial to venous poles of the heart was measured as a straight-line distance, and 733 looped distance was drawn from the same positions at each pole through the centre of each 734 chamber, down the centreline of the looped heart. Looping ratio was determined by dividing 735 looped distance by linear distance. Statistical testing of average looping ratio between 736 experimental conditions was carried out using Kruskal-Wallis with Dunn's multiple 737
comparisons. 738
Heart, ventricle or atrium area at 50hpf was quantified from in situ hybridisations by manually 739 drawing round either myl7, myh7l or myh6 staining area in Fiji. Statistical testing of heart or 740 chamber size between genotypes was carried out using Kruskal-Wallis with Dunn's multiple 741
comparisons. 742

Quantification of hapln1a overexpression was performed by imaging overexpression embryos 743
where myl7 expression was detected using INT/BCIP and hapln1a expression detected using 744 NBT/BCIP. All embryos were imaged using the same microscope settings, and individual 745 images combined into a composite of all experiments. Using the composite, channels were 746 split in Fiji, resulting in the blue and green channels carrying the myl7 stain, and the red channel 747 carrying the hapln1a stain. Background was subtracted in the red channel. The myl7 staining 748 was used to calculate looping ratio for each heart. In addition, each myl7 signal was used to 749 manually trace the whole heart, atrium, AVC and ventricle for each heart, which was saved as 750 a region of interest (ROI) and the area of each chamber was measured in pixels. Next, the 751 hapln1a image was thresholded to generate a binary image. The whole-heart, or chamber-752 specific ROI was applied to the thresholded hapln1a channel, and the number of positive pixels 753 in each ROI recorded. Number of positive pixels are as a % of total number of pixels 754 comprising the heart or the specific chamber could then be calculated and plotted against 755 looping ratio for each heart. Spearmann's correlation coefficient (r) was calculated in 756
GraphPad Prism, with 95% confidence intervals. 
